Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-09-02
2009-12-15
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C530S300000
Reexamination Certificate
active
07632506
ABSTRACT:
The invention relates to peptides which bind to MHC molecules of either Class I or Class II, and their use. The peptides consist of amino acid sequences found in the NY-ESO-1 molecule.
REFERENCES:
patent: 6251603 (2001-06-01), Jager et al.
patent: 6417165 (2002-07-01), Valmori et al.
patent: 6548064 (2003-04-01), Tureci et al.
patent: 6723832 (2004-04-01), Knuth et al.
patent: 6800730 (2004-10-01), Tureci et al.
patent: 7041502 (2006-05-01), Bilsborough et al.
patent: 7115729 (2006-10-01), Knuth et al.
patent: 7385044 (2008-06-01), Tureci et al.
patent: WO-0155393 (2001-08-01), None
patent: WO-03068800 (2003-08-01), None
Fulbright & Jaworski LLP
Ludwig Institute for Cancer Research
Yu Misook
LandOfFree
Identification of new NY-ESO-1 epitopes recognized by CD4+... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of new NY-ESO-1 epitopes recognized by CD4+..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of new NY-ESO-1 epitopes recognized by CD4+... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113925